Medicaid is a vital program for many of America’s most vulnerable patients. Ensuring that it covers these patients is vital for ensuring their continued health care coverage. Drug manufacturers have been caught cheating the government and taxpayers by misrepresenting their drugs in the past — punishing them for this behavior is needed to ensure that they end this practice.
States already have broad latitude to provide a range of services, including home-based care, to children with complex medical conditions under their Medicaid programs. This bill isn’t needed to expand that authority. Drug manufacturers are already subject to a $100,000 maximum penalty for each line of false information they provide so he increased penalties in this bill are unnecessary.